NASDAQ · HROW
Harrow, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for HROW: Nov 09, 2026
Harrow, Inc. Common Stock is expected to report earnings on 11/09/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 3 analysts' forecasts, the consensus EPS forecast for the quarter is $0.17. The reported EPS for the same quarter last year was $0.33.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $0.17 | $0.25 | $0.01 | 3 |
| Dec 2026 | $0.88 | $1.10 | $0.61 | 3 |
| Mar 2027 | $-0.52 | $-0.42 | $-0.63 | 2 |
| Jun 2027 | $0.23 | $0.59 | $-0.12 | 2 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · Fintel · RTTNews · The Motley Fool- Zacks · Oct 9, 7:46 AM EDTDo Options Traders Know Something About Harrow Stock We Don't?Investors need to pay close attention to HROW stock based on the movements in the options market lately.
- Fintel · Sep 9, 7:32 PM EDTLeerink Partners Initiates Coverage of Harrow at OutperformFintel reports that on September 9, 2026, Leerink Partners initiated coverage of Harrow (NASDAQGM:HROW) with a Outperform recommendation. Prior to this coverage initiation, the stock closed at $37.85 on September 8, 2026. Harrow has experienced a price change of +2.38% over the p
- RTTNews · Aug 20, 8:12 AM EDTHarrow's IHEEZO Demonstrates Patient Comfort Benefit In Intravitreal Study(RTTNews) – Harrow, Inc. (HROW), an ophthalmic disease management company, announced positive results from a prospective, randomized study evaluating IHEEZO (chloroprocaine hydrochloride ophthalmic gel) 3% in patients undergoing same-day bilateral intravitreal injections.
- The Motley Fool · Aug 17, 7:43 PM EDTHarrow (HROW) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- MarketBeat · Aug 11, 11:05 AM EDTHarrow Q2 Earnings Call HighlightsHarrow (NASDAQ:HROW) reported second-quarter revenue of $70.7 million, up 11% from a year earlier and about 60% sequentially, as the ophthalmic pharmaceutical company said it entered the second half of 2026 with stronger demand across several products, improved pricing and expand
- Zacks · Aug 10, 8:05 PM EDTHarrow (HROW) Reports Q2 Loss, Misses Revenue EstimatesHarrow (HROW) delivered earnings and revenue surprises of -47.83% and -0.61%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Aug 6, 9:50 AM EDTIronwood Pharmaceuticals (IRWD) Q2 Earnings Top EstimatesIronwood (IRWD) delivered earnings and revenue surprises of +19.23% and -5.66%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Jun 11, 10:47 AM EDTHROW Stock Rises on Relaunch of Ophthalmology Drug Verkazia in the USHarrow shares gain after relaunching Verkazia in the United States, aiming to improve access to an FDA-approved VKC treatment for pediatric patients.
- The Motley Fool · May 12, 3:43 PM EDTHarrow (HROW) Q1 2026 Earnings Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- BNK Invest · May 12, 3:27 PM EDTNoteworthy Tuesday Option Activity: URI, HROW, HIMSAmong the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in United Rentals Inc (Symbol: URI), where a total of 6,133 contracts have traded so far, representing approximately 613,300 underlying shares. That amounts to about 101.8%
- MarketBeat · May 12, 11:10 AM EDTHarrow Q1 Earnings Call HighlightsHarrow (NASDAQ:HROW) executives said the company’s first-quarter results were weighed down by a discrete revenue issue tied to VEVYE coverage and high-deductible patients, but management repeatedly emphasized that underlying demand for its core ophthalmic products is accelerating
- Zacks · May 11, 6:05 PM EDTHarrow (HROW) Reports Q1 Loss, Lags Revenue EstimatesHarrow (HROW) delivered earnings and revenue surprises of -48.24% and -12.17%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Harrow, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.